PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosis

doi:10.4254/wjh.v7.i29.2920

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 7, Issue 29

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (20130)

All Articles published online

The chart showing PDF series, WORD series, HTML series, Tables (1-2) series.

Item

Count

PDF

573

WORD

366

HTML

3358

Tables (1-2)

142

Sum=4439

Featured Article

The chart showing Browse series, Download series.

Item

Count

Browse

12169

Download

897

Sum=13066

Publishing Process of This Article

Item

Count

Browse

1051

Download

1574

Sum=2625

Dec 18, 2015 (publication date) through Apr 18, 2024

Times Cited of This Article

Times Cited (3)

Journal Information of This Article

Publication Name

World Journal of Hepatology

ISSN

1948-5182

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

World J Hepatol. Dec 18, 2015; 7(29): 2920-2926
Published online Dec 18, 2015. doi: 10.4254/wjh.v7.i29.2920

Table 1 Main demographic and clinical characteristics of patients with hepatitis C/B virus liver cirrhosis, defined virus liver cirrhosis and alcoholic and cryptogenic, aggregated as non-virus cirrhosis

	Total (%)	VLC (%)	Alcoholic (%)	Crypto (%)	NVLC (%)
Patients	1079 (100)	729 (100)	102 (100)	248 (100)	350 (100)
Age (range)	57 (19-83)	60 (24-83)	55 (19-80)	49 (19-83)	51 (19-83)
Male sex	620 (57.5)	384 (52.7)	81 (79.4)	155 (62.5)	236 (67.4)
PVT/BCS	352 (32.6)	230 (31.5)	45 (44.1)	77 (31.0)	122 (34.8)
MVT/SVT	53 (4.9)	33 (4.5)	6 (5.8)	14 (5.6)	20 (5.7)
L-M varices	445 (41.2)	574 (78.7)	48 (47.0)	150 (60.4)	245 (70.0)
N° bleeding	360 (33.3)	265 (36.3)	41 (40.1)	54 (21.7)	95 (27.1)
Child A/B/C	416/242/430 (38.5/22.4/39.8)	241/194/294 (33.0/26.6/40.3)	31/53/17 (30.3/51.9/16.6)	129/31/83 (52.0/12.5/33.4)	165/48/17 (47.1/13.7/39.1)

No statistical differences between VLC vs NVLC group: All χ² > 3.85 and P < 0.05. VLC: Virus liver cirrhosis; NVLC: Non-virus cirrhosis; PVT: Portal vein thrombosis; BCS: Budd Chiari syndrome; MVT: Mesenteric vein thrombosis; SVT: Splenic vein thrombosis.

Table 2 Frequencies of thrombophilic genetic factors, PAI-1 4G-4G, MTHFR 677TT, V Leiden 506Q and prothrombin 20210A, in patients with hepatitis C/B virus liver cirrhosis, alcoholic and cryptogenic, aggregated as non-virus cirrhosis

	(A) VLC (%)	Alcoholic (%)	Crypto (%)	(B) NVLC (%)	(A) vs (B)χ²: P value; OR (95%CI)
Patients	729 (100)	102 (100)	248 (100)	350 (100)	-
PAI-1 4G-4G	95 (13.0)	33 (32.3)	89 (35.8)	122 (34.8)	68.2: 0.000; 3.6 (2.6-4.9)
MTHFR 677TT	99 (13.5)	14 (13.7)	63 (25.4)	77 (22.0)	11.7: 0.001; 1.8 (1.3-2.5)
V Leiden 506Q	41 (5.6)	9 (8.8)	22 (8.8)	30 (8.6)	3.3: 0.09; 1.5 (0.9-2.6)
Prothrombin 20210A	25 (3.4)	3 (2.9)	13 (5.2)	16 (4.5)	0.8: 0.39; 1.4 (0.7-2.7)
At least 1 THRGF	218 (29.9)	43 (42.1)	156 (62.9)	199 (56.9)	72.5: 0.000; 3.1 (2.4-4.1)
> 1 THRGF	40 (5.4)	14 (13.7)	30 (12.0)	44 (12.5)	16.5: 0.000; 2.5 (1.6-4.0)

VLC: Virus liver cirrhosis; NVLC: Non-virus cirrhosis; THRGF: Thrombophilic genetic factors.

Citation: Pasta L, Pasta F. PAI-1 4G-4G and MTHFR 677TT in non-hepatitis C virus/hepatitis B virus-related liver cirrhosis. World J Hepatol 2015; 7(29): 2920-2926
URL: https://www.wjgnet.com/1948-5182/full/v7/i29/2920.htm
DOI: https://dx.doi.org/10.4254/wjh.v7.i29.2920